Ireland Immunotherapy Market, By Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, Inhibitors, and Others), By Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Research & Academic Institutions, and Others), By Region, Competition, Forecast and Opportunities, 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationIreland Immunotherapy Market, By Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, Inhibitors, and Others), By Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Research & Academic Institutions, and Others), By Region, Competition, Forecast and Opportunities, 2028
According to National Cancer Registry Ireland (NCRI), age group of population suffering from Leukaemia 75+ years are 30%,65-74 years 24%, 50-64 years 23% and <50years 23% and Death records are 75+ years are 51%, 65-74 years 28%, 50-64 years 12% and <50 years 9%.
Growing Prevalence of Cancer Diseases
Increase in prostate cancer is 114% with 6870 cases, 119% for lung cancer with cases 5450 and 63% for female breast cancer to 5050 cases and 112% for colon cancer to 3810 cases.
Rise in Geriatric Population
On an average 22,321 new cases of cancer are diagnosed each year the almost all 3 quarters 74% of people who dies through cancer are over the age of 65 years.
Growing Awareness for Immunotherapy Among Consumers
Immunotherapy can even be continued during pregnancy because it is based on modified allergens rather than drugs. Due to the extremely low possibility of an allergic reaction, the initial dose is administered in Allergy Ireland under medical supervision. The remaining part of the course of treatment is completed at home.
Recent Developments
In 2022, Novartis announced it had reached an agreement with Sterling Pharma Solutions, a leading global development and manufacturing company, to produce medicine for Novartis (active pharmaceutical ingredient (API)) in Ireland. Sterling Pharma Solutions are producing Novartis APIs for cardiology, immunology, and oncology medicines.
In 1981,
These have been significant developments in the company's portfolio expansion strategy AstraZeneca has invested almost USD 40 billion on cardiovascular disease acquisitions over the past four years through six deals. AstraZeneca has also participated in five deals related to oncology and five deals related to respiratory diseases during this time
In 2019-2020, Lilly has made 18 acquisitions and 58 investments Loxo Oncology acquire for USD 8 billion and IN 2020 acquire Dermiria for USD 1.10 billion
Market Segmentation
The Ireland immunotherapy market can be segmented by technology, indication, end user, and region. Based on technology, the market can be segmented into monoclonal antibodies, cytokines & immunomodulators, inhibitors, and others. Based on indication, the market can be segmented into oncology, autoimmune diseases, infectious diseases, and others. Based on end user, the market can be grouped into hospitals & clinics, ambulatory care centers, research & academic institutions, and others. Based on region, the market is segmented into Dublin, Cork, Galway, and Limerick.
Market Players
Bristol Myers Squibb Co., Merck Sharp & Dohme (MSD) Corp, Pfizer Inc, Roche AG, Eli Lilly & Co, AstraZeneca PLC, Novartis AG, and Janssen Sciences Ireland UC are some of the leading players operating in the Ireland immunotherapy market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | Technology Indication End User |
| Regional Scope | Dublin, Cork, Galway, and Limerick |
| Key Companies Profiled | Bristol Myers Squibb Co., Merck Sharp & Dohme (MSD) Corp, Pfizer Inc, Roche AG, Eli Lilly & Co, AstraZeneca PLC, Novartis AG, Janssen Sciences Ireland UC |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy